UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011031
Receipt No. R000012915
Scientific Title A phase II study of neoadjuvant docetaxel/cyclophosphamide (DC) followed by epirubicin/cyclophosphamide (EC) for triple-negative breast cancer
Date of disclosure of the study information 2013/06/24
Last modified on 2018/03/05 18:26:19

No. Disposal Last modified on Item of update
1 Insert 2013/06/24 20:49:55
2 Update 2013/10/02 10:28:35 Email
3 Update 2013/10/02 10:29:40 Recruitment status
4 Update 2018/03/05 18:25:28 Name of primary sponsor
Organization
Organization
Organization
5 Update 2018/03/05 18:26:19 Recruitment status


Contact us.